Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 14 April 1972:
Vol. 176. no. 4031, pp. 170 - 171
DOI: 10.1126/science.176.4031.170

Articles

The Immune Reaction as a Stimulator of Tumor Growth

Richmond T. Prehn 1

1 Institute for Cancer Research, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111

Various numbers of spleen cells from specifically immunized mice were mixed with constant numbers of target tumor cells, and were inoculated subcutaneously into thymectomized, x-irradiated recipients. Small numbers of admixed immune spleen cells produced a statistically significant, and reproducible, acceleration of tumor growth in the inoculum as compared with controls of either nonimmune spleen cells or spleen cells from animals immune to a different, non-cross-reacting, tumor. Larger. numbers of specifically immune spleen cells, however, produced inhibition of tumor growth. These data imply that the normal immune reaction may have a dual function in relation to neoplasia: (i) stimulation of tumor growth, early in the course of the disease, or whenever the immune reaction is minimal; (ii) inhibition of tumor growth at other times.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.
M. Hedlund, V. Padler-Karavani, N. M. Varki, and A. Varki (2008)
PNAS 105, 18936-18941
   Abstract »    Full Text »    PDF »
A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and Humans.
F. I. Staquicini, A. Tandle, S. K. Libutti, J. Sun, M. Zigler, M. Bar-Eli, F. Aliperti, E. C. Perez, J. E. Gershenwald, M. Mariano, et al. (2008)
Cancer Res. 68, 8419-8428
   Abstract »    Full Text »    PDF »
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.
S. J. Roberts, B. Y. Ng, R. B. Filler, J. Lewis, E. J. Glusac, A. C. Hayday, R. E. Tigelaar, and M. Girardi (2007)
PNAS 104, 6770-6775
   Abstract »    Full Text »    PDF »
Chronic Lymphocytic Leukemia-reactive T Cells during Disease Progression and after Autologous Tumor Cell Vaccines.
E. Gitelson, C. Hammond, J. Mena, M. Lorenzo, R. Buckstein, N. L. Berinstein, K. Imrie, and D. E. Spaner (2003)
Clin. Cancer Res. 9, 1656-1665
   Abstract »    Full Text »    PDF »
Variability of Placental Expression of Cyclin E Low Molecular Weight Variants.
A. Bukovsky, M. Cekanova, M. R. Caudle, J. Wimalasena, J. S. Foster, J. A. Keenan, and R. F. Elder (2002)
Biol Reprod 67, 568-574
   Abstract »    Full Text »    PDF »
Enhanced Growth of Primary Tumors in Cancer-Prone Mice after Immunization against the Mutant Region of an Inherited Oncoprotein.
C. T. Siegel, K. Schreiber, S. C. Meredith, G. B. Beck-Engeser, D. W. Lancki, C. A. Lazarski, Y.-X. Fu, D. A. Rowley, and H. Schreiber (2000)
J. Exp. Med. 191, 1945-1956
   Abstract »    Full Text »    PDF »
The Flip Side of Tumor Immunity.
R. T. Prehn and L. M. Prehn (1989)
Arch Surg 124, 102-106
   Abstract »    PDF »
Rank order of sarcoma susceptibility among mouse strains reverses with low concentrations of carcinogen.
L. Prehn and E. Lawler (1979)
Science 204, 309-310
   Abstract »    PDF »
Multiplicity of the Tumor-Directed Immune Response: Implications for Immunotherapy.
W. R. Beltz and N. L. Levy (1975)
Arch Otolaryngol Head Neck Surg 101, 660-663
   Abstract »    PDF »
Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice.
O. Stutman (1974)
Science 183, 534-536
   Abstract »    PDF »
Stimulation of Cells by Antibody.
W. T. Shearer, G. W. Philpott, and C. W. Parker (1973)
Science 182, 1357-1359
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)